Welcome to Sleepsight
HOW IT WORKS
Activity tracker
Participants are given a modern activity tracker to wear on their wrist, day and night, for the duration of the study.
The watch measures activity levels and sleep, and sends data to a smartphone using wireless technology.
The watch is water proof, and does not need charging.
Smartphone
We provide participants with a Motorola android smartphone, and a mobile contract, at no cost to the participant.
Once a day, participants are asked to complete a short questionnaire on the smartphone, taking no more than 2 minutes to complete, asking about sleep and symptom levels.
We ask that the smartphone we provide is used as their main phone – including making calls, sending messages, and browsing the internet.
12-months
We ask participants to take part in the study for up to 12 months.
Participants will be compensated for their time and effort at the end of the study.
The research should help us to understand how changes in sleep pattern relate to changes in wellbeing.
Sleepsight is funded by the Medical Research Council, and has received ethical approval from the London Dulwich Research Ethics Committee.
We are looking for participants who:
• Have a psychosis diagnosis (including schizophrenia and schizoaffective disorder)
• Are aged between 18-65
• Are under the care of the South London and Maudsley NHS Foundation Trust
• Are able and interested in using the study technology for 12 months
If you’re interested in participating, or are working with a service user who is, please contact us below.
GET INVOLVED
Secure contact form for SLaM service users and clinicians.
Where possible, please include a SLaM ID.
Or contact:
Dr Nicholas Meyer
Department of Psychosis Studies
Institute of Psychiatry, Psychology and Neuroscience
London SE5 8AF
nicholas.meyer@kcl.ac.uk
m: 07835 035587
SLEEPSIGHT TEAM
Sleepsight is a unique collaboration between King’s College London, University of Oxford, University of Surrey, South London and Maudsley NHS Foundation Trust, and Audacious Software.
Nick Meyer is a psychiatrist based at the Institute of Psychiatry, Psychology & Neuroscience at King’s College London, and South London and Maudsley NHS Foundation Trust.
Chris Karr is a software developer at Audacious Software based in Chicago, USA.
Maarten de Vos is Associate Professor at the Institute of Biomedical Engineering, University of Oxford.
Derk-Jan Dijk is Professor of Sleep and Physiology and Director of the Surrey Sleep Research Centre.
Richard Dobson is Professor of Medical and Bioinformatics at King’s College London.
James MacCabe is Reader in the Epidemiology of Psychosis at the Institute of Psychiatry, Psychology & Neuroscience at King’s College London, and South London and Maudsley NHS Foundation Trust.
